IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 40 filers reported holding IBERE PHARMACEUTICALS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,270,219 | +1.8% | 224,997 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $2,231,000 | +1.1% | 224,997 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $2,207,000 | 0.0% | 224,997 | 0.0% | 0.01% | +25.0% |
| Q1 2022 | $2,207,000 | +0.7% | 224,997 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,192,000 | +0.6% | 224,997 | 0.0% | 0.00% | -55.6% |
| Q3 2021 | $2,180,000 | +0.2% | 224,997 | 0.0% | 0.01% | -10.0% |
| Q2 2021 | $2,176,000 | – | 224,997 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |